Join the limbic and a panel of experts to discuss the gastrointestinal cancer trials unveiled at the recent ASCO 2020 virtual meeting and what they mean for clinical practice in Australia.
There will be an opportunity to ask the panel questions during the webinar. Alternatively, you can submit your questions to [email protected] before the event.
Thursday, 25th June 2020, 6:30pm – 7:30pm (AEST)
Note: A reminder email will be sent when the webinar is about to begin
Hosted by:
Professor Chris Karapetis: Head, Medical Oncology, Flinders Medical Centre. Network Director, Cancer Services, Southern Area LHN, Adelaide. Director, Clinical Research in Medical Oncology, Flinders Medical Centre and Flinders Centre for Innovation in Cancer.
With special guests:
Professor Eva Segelov: Professor/Director of Oncology, Monash Health and Monash University. Board Member, Australasian Gastrointestinal Trials Group (AGITG). Co-Founder, Commonwealth Neuroendocrine Tumour Collaboration (CommNETS)
Doctor Christopher Jackson: Consultant Medical Oncologist at Mercy Cancer Care, Dunedin. Clinical Leader for Oncology Research, Dunedin Hospital. Co-founder of Mercy Cancer Care. Medical Director, Cancer Society of New Zealand.
Dr Matthew Burge: Medical oncologist, Icon Cancer Centre, Chermside. Staff Specialist at the Royal Brisbane Hospital, QLD.
Thursday, 25th June 2020, 6:30pm – 7:30pm (AEST)
Note: A reminder email will be sent when the webinar is about to begin
This webinar was developed independently by the limbic. Thank you to Merck Healthcare Pty Ltd for providing the financial support that made it possible.
